Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Dyslipidemia

Free Subscription Articles published in Circulation Retrieve available abstracts of 24 articles: HTML format Text format

Single Articles

December 2017
1. HESS GP, Natarajan P, Faridi KF, Fievitz A, et al
   Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy: Payer Approvals and Rejections, and Patient Characteristics for Successful Prescribing.
   Circulation. 2017;136:2210-2219.
   PubMed     Text format     Abstract available
   
   
   October 2017
2. GAUDINO M, Antoniades C, Benedetto U, Deb S, et al
   Mechanisms, Consequences, and Prevention of Coronary Graft Failure.
   Circulation. 2017;136:1749-1764.
   PubMed     Text format     Abstract available
   
   
   September 2017
3. VALLEJO-VAZ AJ, Robertson M, Catapano AL, Watts GF, et al
   LDL-Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men with Primary Elevations of LDL-Cholesterol Levels of 190 mg/dL or Above: Analyses from the WOSCOPS 5-year Randomised Trial and 20-year Observational Follow-Up.
   Circulation. 2017 Sep 6. pii: CIRCULATIONAHA.117.027966.
   PubMed     Text format     Abstract available
   
   
   August 2017
4. DROUIN-CHARTIER JP, Tremblay AJ, Bergeron J, Lamarche B, et al
   The Low-Density Lipoprotein Receptor Genotype Is a Significant Determinant of the Rebound in Low-Density Lipoprotein Cholesterol Concentration After Lipoprotein Apheresis Among Patients With Homozygous Familial Hypercholesterolemia.
   Circulation. 2017;136:880-882.
   PubMed     Text format    
   
   
   July 2017
5. LERMAN JB, Joshi AA, Chaturvedi A, Aberra TM, et al
   Coronary Plaque Characterization in Psoriasis Reveals High-Risk Features That Improve After Treatment in a Prospective Observational Study.
   Circulation. 2017;136:263-276.
   PubMed     Text format     Abstract available
   
   
   
6. BLOM DJ, Averna MR, Meagher EA, du Toit Theron H, et al
   Long-Term Efficacy and Safety of the Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide in Patients With Homozygous Familial Hypercholesterolemia.
   Circulation. 2017;136:332-335.
   PubMed     Text format    
   
   
   June 2017
7. BRAAMSKAMP MJAM, Langslet G, McCrindle BW, Cassiman DM, et al
   Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children with Heterozygous Familial Hypercholesterolemia: The CHARON Study.
   Circulation. 2017 Jun 7. pii: CIRCULATIONAHA.116.025158.
   PubMed     Text format     Abstract available
   
   
   March 2017
8. PEREZ DE ISLA L, Alonso R, Mata N, Fernandez-Perez C, et al
   Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry.
   Circulation. 2017 Mar 8. pii: CIRCULATIONAHA.116.024541.
   PubMed     Text format     Abstract available
   
   
   November 2016
9. LI P, Yin YL, Guo T, Sun XY, et al
   Inhibition of Aberrant MicroRNA-133a Expression in Endothelial Cells by Statin Prevents Endothelial Dysfunction by Targeting GTP Cyclohydrolase 1 in Vivo.
   Circulation. 2016;134:1752-1765.
   PubMed     Text format     Abstract available
   
   
   
10. SAITO Y, Okada S, Ogawa H, Soejima H, et al
    Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients with Type 2 Diabetes: 10-year Follow-up of a Randomized Controlled Trial.
    Circulation. 2016 Nov 15. pii: CIRCULATIONAHA.116.025760.
    PubMed     Text format     Abstract available
    
    
    
11. MAHMOODI BK, Cushman M, Naess IA, Allison MA, et al
    Association of Traditional Cardiovascular Risk Factors with Venous Thromboembolism: An Individual Participant Data Meta-analysis of Prospective Studies.
    Circulation. 2016 Nov 9. pii: CIRCULATIONAHA.116.024507.
    PubMed     Text format     Abstract available
    
    
    
12. DE FERRANTI S, Sheldrick RC, Wong JB
    Response by de Ferranti et al to Letter Regarding Article, "Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES)".
    Circulation. 2016;134:e395-e396.
    PubMed     Text format    
    
    
    
13. PEREZ DE ISLA L, Saltijeral Cerezo A, Mata P
    Letter by Perez de Isla et al Regarding Article, "Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES)".
    Circulation. 2016;134:e393-e394.
    PubMed     Text format    
    
    
    October 2016
14. BOZKURT B, Aguilar D, Deswal A, Dunbar SB, et al
    Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Oct 31. pii: CIR.0000000000000450.
    PubMed     Text format    
    
    
    
15. SYME C, Czajkowski S, Shin J, Abrahamowicz M, et al
    Glycerophosphocholine Metabolites and Cardiovascular Disease Risk Factors in Adolescents: A Cohort Study.
    Circulation. 2016 Oct 18. pii: CIRCULATIONAHA.116.022993.
    PubMed     Text format     Abstract available
    
    
    September 2016
16. RAGHUVEER G, White DA, Hayman LL, Woo JG, et al
    Cardiovascular Consequences of Childhood Secondhand Tobacco Smoke Exposure: Prevailing Evidence, Burden, and Racial and Socioeconomic Disparities: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Sep 12. pii: CIR.0000000000000443.
    PubMed     Text format     Abstract available
    
    
    
17. HOVINGH GK, Kastelein JJ
    Diagnosis and Management of Individuals With Heterozygous Familial Hypercholesterolemia: Too Late and Too Little.
    Circulation. 2016;134:710-2.
    PubMed     Text format    
    
    
    August 2016
18. VOS MB, Kaar JL, Welsh JA, Van Horn LV, et al
    Added Sugars and Cardiovascular Disease Risk in Children: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Aug 22. pii: CIR.0000000000000439.
    PubMed     Text format     Abstract available
    
    
    July 2016
19. NANCHEN D, Gencer B, Muller O, Auer R, et al
    Prognosis of Patients with Familial Hypercholesterolemia After Acute Coronary Syndromes.
    Circulation. 2016 Jul 26. pii: CIRCULATIONAHA.116.023007.
    PubMed     Text format     Abstract available
    
    
    
20. CHOMISTEK AK, Henschel B, Eliassen AH, Mukamal KJ, et al
    Frequency, Type, and Volume of Leisure-Time Physical Activity and Risk of Coronary Heart Disease in Young Women.
    Circulation. 2016;134:290-9.
    PubMed     Text format     Abstract available
    
    
    
21. PATON DM
    Letter by Paton Regarding Article, "Knowing the Prevalence of Familial Hypercholesterolemia Matters".
    Circulation. 2016;134:e17-8.
    PubMed     Text format    
    
    
    
22. HAAS ME, Levenson AE, Sun X, Liao WH, et al
    The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Nephrotic Syndrome-Associated Hypercholesterolemia.
    Circulation. 2016;134:61-72.
    PubMed     Text format     Abstract available
    
    
    
23. RODRIGUEZ F, Knowles JW
    Enough Evidence, Time to Act!
    Circulation. 2016;134:20-3.
    PubMed     Text format    
    
    
    
24. PERAK AM, Ning H, de Ferranti SD, Gooding HC, et al
    Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype.
    Circulation. 2016;134:9-19.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: